Evidence map›Paper›PMID 33470192›Full record

ArticleeLife2021

Metabolomic profiling of rare cell populations isolated by flow cytometry from tissues.

Andrew W DeVilbiss, Zhiyu Zhao, Misty S Martin-Sandoval, Jessalyn M Ubellacker, Alpaslan Tasdogan, Michalis Agathocleous, Thomas P Mathews, Sean J Morrison

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 85 citations in OpenAlex.

  1. Loss of TCA cycle turning promotes stem cell function.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Stem cell functionbioRxiv : the preprint server for biology · 2026
    Article
  11. Mass Spectrometry as a Tool for Metabolomics in Cancer.Advances in experimental medicine and biology · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrew W DeVilbissChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.ORCID 0000-0002-9739-2543
Zhiyu ZhaoChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.ORCID 0000-0001-6308-6997
Misty S Martin-SandovalChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.
Jessalyn M UbellackerChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.
Alpaslan TasdoganChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.
Michalis AgathocleousChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.
Thomas P MathewsChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.ORCID 0000-0002-9355-8243
Sean J MorrisonChildren's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.ORCID 0000-0003-1587-8329
The University of Texas Southwestern Medical Center · USHoward Hughes Medical Institute · US

Funding

The Metabolic Regulation of Melanoma MetastasisU01CA228608 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MORRISON, SEAN J · 2019 to 2023
$2.9M
Role of HSF1 in Hematopoietic Stem Cell Maintenance and FunctionF32HL135975 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI DEVILBISS, ANDREW W · 2017 to 2019
$179k
Howard Hughes Medical InstituteNCI NIH HHS U01 CA228608NHLBI NIH HHS F32 HL135975NIH HHS DK11875NIH HHS F32 HL 135975
6 · The paper itself

Abstract

Little is known about the metabolic regulation of rare cell populations because most metabolites are hard to detect in small numbers of cells. We previously described a method for metabolomic profiling of flow cytometrically isolated hematopoietic stem cells (HSCs) that detects 60 metabolites in 10,000 cells (Agathocleous et al., 2017). Here we describe a new method involving hydrophilic liquid interaction chromatography and high-sensitivity orbitrap mass spectrometry that detected 160 metabolites in 10,000 HSCs, including many more glycolytic and lipid intermediates. We improved chromatographic separation, increased mass resolution, minimized ion suppression, and eliminated sample drying. Most metabolite levels did not significantly change during cell isolation. Mouse HSCs exhibited increased glycerophospholipids relative to bone marrow cells and methotrexate treatment altered purine biosynthesis. Circulating human melanoma cells were depleted for purine intermediates relative to subcutaneous tumors, suggesting decreased purine synthesis during metastasis. These methods facilitate the routine metabolomic analysis of rare cells from tissues.

Indexed as

MetabolomeAnimalsChromatography, LiquidFemaleFlow CytometryHydrophobic and Hydrophilic InteractionsMaleMass SpectrometryMetabolomicsMicecirculating cancer cellhematopoietic stem cellmelanomametabolismmetabolomicsmouseregenerative medicinestem cells

Identifiers

PMID33470192
PMCPMC7847306
OpenAlexW3123766632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.